David Southwell

David Southwell

Directeur/Membre du Conseil chez ROCKET PHARMACEUTICALS, INC.

Fortune : 2 M $ au 31/05/2026

65 ans
Health Technology
Finance
Technology Services

Profil

Mr. David P.
Southwell
is a Chief Executive Officer at Volastra Therapeutics, Inc., an Independent Director at Rocket Pharmaceuticals, Inc., an Independent Director at PTC Therapeutics, Inc. and an Independent Director at THL Credit Secured Floating Rate Debt Ltd. He is on the Board of Directors at Sensorium Therapeutics, Inc., Rocket Pharmaceuticals Ltd., Rocket Pharmaceuticals, Inc., PTC Therapeutics, Inc., Panel Intelligence LLC and THL Credit Secured Floating Rate Debt Ltd. Mr. Southwell was previously employed as a President, Chief Executive Officer & Director by TScan Therapeutics, Inc., a President, Chief Executive Officer & Director by Inotek Pharmaceuticals Corp., a Chief Financial Officer, Director & Executive VP by Human Genome Sciences, Inc., an Independent Director by First Eagle Alternative Capital BDC, Inc., a Chairman by BioSphere Medical, Inc., a Chief Financial Officer & Executive Vice President by Sunovion Pharmaceuticals, Inc., a Vice President-Investment Banking by Lehman Brothers, Inc., and a Chief Financial Officer by Bionevia Pharmaceuticals, Inc. He also served on the board at Spero Therapeutics, Inc., inVentiv Health, Inc. and MedPanel, Inc. He received his undergraduate degree from William Marsh Rice University and an MBA from Tuck School of Business at Dartmouth.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/04/2026 22 500 ( 0,03 % ) 2 M $ 31/05/2026
24/03/2026 95 160 ( 0,09 % ) 292 141 $ 31/05/2026

Postes actifs de David Southwell

SociétésPosteDébut
PTC THERAPEUTICS, INC. Directeur/Membre du Conseil 01/12/2005
ROCKET PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2018
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 12/09/2023
Directeur/Membre du Conseil 05/01/2018
Directeur/Membre du Conseil 13/06/2009
Directeur Général 27/05/2025

Anciens postes connus de David Southwell

SociétésPosteFin
TSCAN THERAPEUTICS, INC. Directeur Général 27/03/2023
SPERO THERAPEUTICS, INC. Directeur/Membre du Conseil 01/04/2019
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Southwell

Formation de David Southwell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Finance

Consumer Services

Commercial Services

Technology Services

Health Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Southwell
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇